ADAPTABLE, the aspirin study, is a national, multi-site pragmatic clinical trial designed to determine the safest and most effective dose of aspirin to prevent heart attacks and strokes for those living with heart disease. The study recently marked an important milestone – 15,076 participants have enrolled, exceeding the enrollment target of 15,000 participants. Congratulations to participants, patient partners, clinicians and researchers!
Join the Conquest is a free website that allows the public to find and express interest in your research study! Any UNC study or trial that is recruiting human subjects can easily list a study on the website and be contacted by potentially eligible participants. The UNC-specific site is maintained by UNC’s North Carolina Translational and Clinical Sciences (NC TraCS) Institute.
A Nature news story shines a spotlight on the increase in infectious diseases associated with the opioid epidemic while highlighting the work of researchers at the University of North Carolina at Chapel Hill, RTI International, and Emory University.
TraCS Director, affiliated faculty and researchers featured in video produced for the ADA scientific conference
The Patient-Centered Outcomes Research Institute (PCORI) and the American Diabetes Association (ADA) teamed up to produce a video that highlights PCORI-funded research, including the MONITOR Trial and Rethink the Strip, as well as PCORnet, the National Patient-Centered Clinical Research Network.